MYC and liposarcoma: The transcription factor c-Myc is amplified/upregulated in several sarcomas with complex genetics including leiomyosarcoma, osteosarcoma, liposarcoma, chondrosarcoma and rhabdomyosarcoma, and this has been associated with cancer aggressiveness and poor clinical outcome (1, 5–11).